HemaSphere (Jun 2022)

S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES

  • H. Gisslinger,
  • C. Klade,
  • P. Georgiev,
  • D. Krochmalczyk,
  • L. Gercheva-Kyuchukova,
  • M. Egyed,
  • P. Dulicek,
  • A. Illes,
  • H. Pylypenko,
  • L. Sivcheva,
  • J. Mayer,
  • V. Yablokova,
  • V. Empson,
  • K. Krejcy,
  • H. Hasselbalch,
  • R. Kralovics,
  • J.-J. Kiladjian

DOI
https://doi.org/10.1097/01.HS9.0000843676.80508.b5
Journal volume & issue
Vol. 6
pp. 97 – 98

Abstract

Read online

No abstracts available.